An Implementation and Biobehavioral Study of Temporomandibular Joint and Muscle Disorder (TMJMD)
NCT ID: NCT00952900
Last Updated: 2015-06-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
456 participants
INTERVENTIONAL
2008-08-31
2014-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Digitally Trained Applied Relaxation for Treatment of Temporomandibular Pain
NCT07129096
Temporomandibular Disorder (TMD) Pain in Response to Jaw Advancement in People With TMD and Obstructive Sleep Apnea
NCT02685202
Art-Based Pain Assessment Tool in Patients With Temporomandibular Joint Disorders
NCT07018791
Individualized Assessment and Treatment for TMD
NCT04376333
Brief Treatment for Temporomandibular Pain
NCT00067366
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early Biobehavioral Intervention
This intervention involves the use of non-invasive treatment modalities such as relaxation/biofeedback, stress management, and cognitive coping skills. It is based upon previous clinical research studies demonstrating the efficacy of this intervention in allowing acute TMD patients to better cope with stress and lifestyle issues that produce the TMD pain/discomfort.
Biobehavioral
6 sessions of Biobehavioral treatment modalities that include relaxation/biofeedback, stress management, and coping skills techniques.
Attention Control Group
This intervention involves the presentation of helpful information to patients that explains etiology and potential treatment modalities used to modify/reduce TMD pain/discomfort.
Active Coping/Attention Intervention
6 sessions of didactic educational techniques to expose patients to the causes of TMD, as well as introducing them to traditional treatment modalities for intervening with acute TMD problems.
No Active Treatment Comparison Group
Unlike the other two treatment groups, that involve high-risk acute TMD patients, this group includes low-risk acute TMD patients. Past studies have shown that these low risk patients do not need any early intervention in order to prevent chronicity.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Biobehavioral
6 sessions of Biobehavioral treatment modalities that include relaxation/biofeedback, stress management, and coping skills techniques.
Active Coping/Attention Intervention
6 sessions of didactic educational techniques to expose patients to the causes of TMD, as well as introducing them to traditional treatment modalities for intervening with acute TMD problems.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject's First Acute Jaw Pain/Discomfort Episode Must Have First Developed Within the Last 6 Months
Exclusion Criteria
* TMD pain/discomfort of greater than 6 months' duration
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Texas A&M University
OTHER
The University of Texas at Arlington
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Robert J. Gatchel
Robert J. Gatchel, Ph.D., ABPP, Professor and Chair, Department of Psychology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert J. Gatchel, Ph.D., ABPP
Role: PRINCIPAL_INVESTIGATOR
The University of Texas at Arlington
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UT Arlington
Arlington, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.